|Day Low/High||75.36 / 76.20|
|52 Wk Low/High||52.83 / 80.19|
One of pharma's biggest CEO's talks M&A action on the exchange.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of results from KEYNOTE-181, a Phase 3 trial investigating KEYTRUDA, Merck's anti-PD-1 therapy, as monotherapy for the second-line treatment of...
Report on positive results of new drugs to treat ovarian and other cancers sends shares higher.
Jim Cramer talks about the Fed, and outlines your game plan.
And it is happening not a moment too soon.
Big pharma could be primed for an M&A Boom after Bristol-Myers Squibb's blockbuster deal for Celgene.
People will still take their medicine regardless of the state of the economy.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that KEYTRUDA, Merck's anti-PD-1 therapy, has simultaneously received five new approvals from the Japan Pharmaceuticals and Medical Devices Agency (PMDA), including...
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc.
The health care sector may a good place to weather this storm. Here is why and how to play it.
Take upbeat outlooks for equities with a grain of salt, and try these sectors to stay safe.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C.
The most recent short interest data has been released for the 12/14/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
DARMSTADT, Germany, and NEW YORK, December 21, 2018 /PRNewswire/ -- Not intended for UK-based media Merck KGaA, Darmstadt, Germany, and Pfizer Inc.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.
DARMSTADT, Germany, December 20, 2018 /PRNewswire/ -- Not intended for UK-based media Agreement enables Merck KGaA, Darmstadt, Germany, to maintain an investment in the rapidly advancing oncology field of CAR-T , while focusing its R&D efforts Intrexon...
AstraZeneca and Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced positive results from the randomized, open-label, controlled, Phase 3 SOLO-3 trial of LYNPARZA tablets in 266 patients with relapsed ovarian cancer after...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.